Inovio Pharmaceuticals, Inc (INO)

CIK 1055726 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inovio Pharmaceuticals, Inc.

Recent SEC filings

FiledFormAccession number
Nov 6, 2026424B50001193125-26-451932
Nov 6, 2026FWP0001193125-26-450394
Nov 5, 20268-K0001193125-26-449853
Nov 5, 2026424B50001193125-26-449837
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002763
Nov 2, 20268-K0001193125-26-442648
Oct 6, 20268-K0001193125-26-415555
Aug 12, 202610-Q0001055726-26-000023
Aug 12, 20268-K0001055726-26-000024
Aug 12, 2026SCHEDULE 13G/A0000919574-26-004959
Aug 7, 2026SCHEDULE 13G0001346824-26-000216
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002045
Jul 31, 20268-K0001193125-26-326785
Jul 31, 2026SCHEDULE 13G0002100119-26-001406
Jul 30, 2026424B50001193125-26-326370
Jul 29, 2026424B50001193125-26-323616
Jul 29, 20268-K0001193125-26-323628
Jul 10, 2026EFFECT9999999995-26-002261
Jul 2, 2026S-30001193125-26-294457
May 26, 2026S-80001193125-26-237305
May 21, 202640001771498-26-000005
May 21, 202640001278219-26-000001
May 21, 202640001669080-26-000003
May 21, 202640001936799-26-000006
May 21, 202640001273306-26-000001